David T. Scadden
Harvard University(US)Massachusetts General Hospital(US)Harvard Stem Cell Institute(US)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Mesenchymal stem cell research, Viral-associated cancers and disorders, Cancer Cells and Metastasis
Most-Cited Works
- → Osteoblastic cells regulate the haematopoietic stem cell niche(2003)3,397 cited
- → Mesenchymal and haematopoietic stem cells form a unique bone marrow niche(2010)3,322 cited
- → The bone marrow niche for haematopoietic stem cells(2014)2,354 cited
- → Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer(2004)1,946 cited
- → The stem-cell niche as an entity of action(2006)1,830 cited
- → AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients(2007)1,760 cited
- →